TY - JOUR
T1 - Hypertensie die slecht op behandeling reageert
AU - de Jager, Rosa
AU - Rutten, Frans
AU - Bots, Michiel
AU - Spiering, Wilko
AU - Blankestijn, Peter J.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - De Jager RL, Rutten FH,Bots ML, Spiering W, Blankestijn PJ. Treatment-resistant hypertension. Huisarts Wet 2016;59(1):24-6. At least 65% of the patients with hypertension do not achieve the target blood pressure of <140/90 mmHg. A patient is considered to have treatment-resistant hypertension if other causes of poorly controlled blood pressure have been excluded, such as non-adherence, secondary causes, and the white coat effect. If there is evidence of a secondary cause or treatment-resistant hypertension, the patient can be referred to a hypertension specialist. In addition, some patients with treatment-resistant hypertension may benefit from new, experimental treatments, such as renal denervation or baroreflex activation therapy.
AB - De Jager RL, Rutten FH,Bots ML, Spiering W, Blankestijn PJ. Treatment-resistant hypertension. Huisarts Wet 2016;59(1):24-6. At least 65% of the patients with hypertension do not achieve the target blood pressure of <140/90 mmHg. A patient is considered to have treatment-resistant hypertension if other causes of poorly controlled blood pressure have been excluded, such as non-adherence, secondary causes, and the white coat effect. If there is evidence of a secondary cause or treatment-resistant hypertension, the patient can be referred to a hypertension specialist. In addition, some patients with treatment-resistant hypertension may benefit from new, experimental treatments, such as renal denervation or baroreflex activation therapy.
UR - http://www.scopus.com/inward/record.url?scp=84954304673&partnerID=8YFLogxK
U2 - 10.1007/s12445-016-0017-0
DO - 10.1007/s12445-016-0017-0
M3 - Article
AN - SCOPUS:84954304673
SN - 0018-7070
VL - 59
SP - 24
EP - 26
JO - Huisarts en Wetenschap
JF - Huisarts en Wetenschap
IS - 1
ER -